1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow placebo.: new trials by email Literature Review of placebo. trials Research Report on placebo.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin placebo., TMC649128., placebo - Hepatitis C Virus | Phase 1 | Terminated | Tibotec BVBA | 14 | 2011-06-01 | 2012-10-26 |
Hepatitis C (1)
Tibotec BVBA (1)
Netherlands (1) · Poland (1)